Supplementation of rumen-undegradable protein to the diets of early lactation Holstein cows on grass pasture.

The objectives were to evaluate supplements differing in rumen-undegradable protein (RUP) on the performance of early lactation cows on grass pasture. Twenty-four Holstein cows averaging 68 d of lactation and 39.8 kg/d of milk were rotationally grazed on predominantly Dactylis glomerata pasture for 8 wk.

Evaluation of a mobile computerized grain feeder for lactating cows grazing grass pasture.

The objective of this study was to evaluate a mobile computerized grain feeder for use to feed individually Holstein cows grazing grass pasture. Thirty-two Holstein cows averaging 95 d of lactation and 39.3 kg/d of milk were rotationally grazed on predominantly Dactylis glomerata pastures for 9 wk starting in early May.

Lamb wave scattering analysis for reflector characterization.

The potential use of guided waves for defect characterization is studied. The influence of defect shape and size on transmitted and reflected fields is considered. Using the hybrid boundary element technique, the reflection and transmission coefficients for selected guided wave modes are numerically calculated and compared to experimental data.

Effect of fish meal and expeller-processed soybean meal fed to dairy cows receiving bovine somatotropin (sometribove).

Forty-eight multiparous cows were blocked by calving date and milk production and assigned randomly to a TMR formulated to contain 68 or 55% of dietary CP as ruminally degradable CP. Diets contained corn silage, alfalfa haylage, and ground corn. Supplemental CP was soybean meal for the control diet or a combination of soybean meal, expeller-processed soybean meal, and fish meal for the low degradable protein diet.

Effects of a growth hormone-releasing factor analogue and an estradiol-trenbolone acetate implant on somatotropin, insulin-like growth factor I, and metabolite profiles in growing Hereford steers.

Hereford steers (290 +/- 6 kg of BW) were implanted (n = 4) with 140 mg of trenbolone acetate (TBA) and 28 mg of estradiol-17 beta (E2 beta) or nonimplanted (controls, n = 4). In Trial 1, effects of a single i.v.